Arna Pharma and Slate Run Pharmaceuticals have finalized a significant joint venture (JV), establishing a new specialized pharmaceutical entity poised…
Read More
Isomorphic Labs Secures $2.1 Billion in Series B Funding to Accelerate AI-Driven Drug Discovery and Development
AI drug design and development firm Isomorphic Labs has successfully closed a significant $2.1 billion Series B funding round, marking…
Read More
ACROBiosystems Enhances Global Licensing for HEK293 Functional Cell Lines to Accelerate Biopharmaceutical R&D
ACROBiosystems has announced a significant upgrade to its global licensing solution for HEK293 functional cell lines, a move poised to…
Read More
Daiichi Sankyo Partners with Waiv to Accelerate Digital Pathology Biomarker Discovery for Antibody-Drug Conjugate Programs
In a strategic move to enhance precision in oncology drug development, Japanese pharmaceutical giant Daiichi Sankyo has announced a significant…
Read More
Loneliness Linked to Lower Baseline Memory in Older Adults but Does Not Accelerate Long-Term Cognitive Decline According to Large European Study
A comprehensive longitudinal study involving more than 10,000 participants across Europe has revealed a complex relationship between subjective feelings of…
Read More
Ray Therapeutics Secures $125 Million Series B Funding to Accelerate Vision Restoration Pipeline
Ray Therapeutics, a biopharmaceutical company at the forefront of developing novel gene therapies for vision restoration, has successfully closed a…
Read More
Loneliness Linked to Lower Initial Memory Scores in Older Adults But Does Not Accelerate Cognitive Decline Over Time Study Finds
The relationship between subjective feelings of social isolation and cognitive health has long been a focal point of geriatric research,…
Read More
Boehringer Ingelheim Establishes Cutting-Edge AI and Machine Learning Hub in London to Accelerate Targeted Medicine Discovery
Boehringer Ingelheim has officially launched a new, state-of-the-art Artificial Intelligence (AI) and Machine Learning (ML) center in London’s King’s Cross,…
Read More
Kailera Therapeutics Secures $625 Million in Landmark IPO to Accelerate Obesity Drug Development
Obesity-focused biotechnology firm Kailera Therapeutics has successfully launched its Initial Public Offering (IPO), raising an impressive $625 million. This significant…
Read More
Amazon Web Services Launches AI Drug Discovery Platform to Accelerate Novel Therapy Development
Amazon Web Services (AWS) has unveiled a groundbreaking artificial intelligence (AI) application designed to significantly accelerate the design and testing…
Read MoreYOU MAY HAVE MISSED
